Background
Prion diseases constitute a group of unique neurodegenerative disorders, which naturally afflict a number of mammalian species including humans. Although our understanding remains incomplete, considerable evidence supports the "protein-only" hypothesis, which purports that the agent ("prion") responsible for both transmission and consequent pathogenesis is predominantly composed of misfolded conformers of the normal cellular prion protein PrP
C [
1]. Additional discriminating features of the aberrant prion protein include increased β-sheet content [
2,
3], reduced solubility and increased tendency to aggregate, and typically heightened protease resistance [
4‐
6]. Due to the characteristic protease resistant core, limited proteolysis with proteinase K (PK) truncates the N-terminus of the misfolded protein, producing PrP
res, whilst PrP
C is completely degraded, allowing a convenient biochemical differentiation of these two prion protein isoforms.
An intriguing but somewhat perplexing aspect of prion biology is the several instances in transmission studies, encompassing many prion strains, where infectivity titres and PrP
res levels (as detected by biochemical assessment of inocula) do not faithfully correlate. Illustrating this are pre-clinical prion infections after low dose transmissions [
7], BSE infectivity in tongue and nasal mucosa [
8] and slowly sedimenting high titres of infectivity separated from PrP
res in 'fast' prion strains [
9]. Further examples have occurred during cross species transmissions including intracerebral inoculation of hamster prions to mice [
10], primary passage of bovine prions to rodents [
11,
12], scrapie prions peripherally introduced into mice [
13] and transmission of three distinct prion strains (human, hamster scrapie, murine scrapie) into transgenic mice expressing the murine equivalent of a human prion protein gene mutation [
14]. In addition, PrP
res generated through protein misfolding cyclic amplification (PMCA) evinces a longer incubation period (indicative of a lower titre) despite western blot detection levels equivalent to those observed in the original seeding inoculum [
15]. This PMCA study suggests that a component within the original inoculum, which perhaps does not propagate or amplify as well as PrP
res, may contribute to the more efficient transmission. Although PrP
res is inextricably linked to prion infectivity, these numerous examples clearly illustrate the poorly understood complexities of this relationship.
The precise cellular location of PrP
C misfolding and conversion also remains speculative (reviewed in [
16]), as does the contribution of cellular co-factors to conversion efficiency, although the participation of a species-specific protein [
17‐
19], or negatively charged macromolecules such as nucleic acids [
20‐
24] and glycosaminoglycans [
25‐
29] has been posited. In contrast, evidence exists correlating the efficiency of prion propagation and transmission with the size of prion multimers serving as templates for conversion [
30,
31]. Acknowledging the aforementioned uncertainties, the current study investigated whether such observed disparities between infectivity titres and PrP
res levels could be resolved to a subcellular level and thereby provide a useful model for insights into the molecular basis of this observation. To address this aim, we utilized fractionation of MoRK13 cells infected with M1000 prions to explore the contributions of subcellular co-factors and cognate prion protein species to the efficiency of transmission.
Discussion
The protein-only hypothesis states that misfolded conformers of the normal cellular prion protein are the principal component of the agent responsible for transmitting prion disease [
1]. However, previously observed examples of high infectivity titres associated with very low or undetectable PrP
res, the commonly utilized surrogate prion marker, suggest a poorly understood spectrum of infectious prions. Assessing the subcellular environment of the most infectious prions may provide information about optimal pH or metal content conditions, implicate membrane domains, or subcellular co-factors involved in localisation of highly efficient prions. Investigation of the subcellular distribution of prion infectivity and corresponding PrP
res levels has been previously reported, albeit to a limited extent. However, absent in prior studies were attempts to explore what determines the intracellular topographical diversity of prions or the molecular basis of any observed discrepancies in PrP
res and infectivity levels.
The present study clearly indicates that not all prion infectivity is associated with lipid rafts, although the significance of the lipid raft microenvironment in PrP
C misfolding and prion conversion is yet to be resolved, with experimental evidence both for and against lipid raft localisation as an optimal site (reviewed in [
16]). In complete agreement with the protein-only hypothesis, lipid raft and EE marker associated infectivity and PrP
res were shown to correlate in the MoRK13-inf model. In contrast however, ER/MT marker enriched fractions contained much greater infectivity when reported to relative PrP
res content. That lipid raft and ER/MT enriched fractions contain the same infectivity levels indicates some biological redundancy or relative inefficiency of the lipid raft localised prions, and/or higher efficiency of ER/MT localised prions, prompting further investigation.
Cell-free conversion studies have shown there is a role for cellular co-factors, such as nucleic acid or other polyanionic molecules, in the efficiency of prion conversion and propagation [
21‐
23,
29,
54]. Perhaps militating against a prominent role of specific co-factors contributing to the transmission efficiency of the MoRK13-inf subcellular fractions, infectivity of brain derived M1000 prions was not significantly differentially enhanced by dilution across various subcellular fractions. However, an explanation for this result is that the transmissible prions within M1000 brain homogenate were already largely in an optimal state, pre-formed and associated with the necessary co-factors required for infection. Therefore additional exogenous co-factors supplied via the MoRK13 or vecRK13 subcellular fractions were somewhat superfluous. Alternatively, the fractionation procedure itself may have inactivated any critical co-factors, such that they were not able to significantly enhance the infectivity of M1000 brain homogenate. In fact, there was a clear trend for increased PrP
res propagation by recipient cells after infection with M1000 diluted in subcellular fractions compared to the lysis buffer only control, independent of whether the fractions contained PrP
C. This may indicate that incompletely defined but relatively ubiquitous 'cellular co-factors' contribute to the efficiency of
in vitro prion transmission, which would be consistent with previous studies.
Numerous prion strains exist, evident in both naturally occurring human [
55,
56] and animal [
38,
57‐
60] prion disease, as well as those adapted to laboratory based animal models. One hypothesis for what determines different strains is the tertiary structure of the prion conformer, possibly affected by metals, co-factors or binding partners [
61]. It is also believed that prions may adopt various stable tertiary conformations, and there is evidence of simultaneous propagation of more than one prion strain within the brain [
55,
62,
63]. Furthermore, super-infection experiments indicate that the more infectious strain will predominate and determine disease expression [
64‐
66]. Prion strains can be classified by their distinctive neuropathological lesion profiles, incubation periods, PrP
res glycosylation patterns and electrophoretic mobilities [
39,
42,
43,
46]. As RK13 cells are capable of supporting and maintaining propagation of many prion strains [
67], and each fraction represented different subcellular localisations and potential binding partners, we explored the possibility that MoRK13-inf fractions contained structurally distinct prions of variable transmission efficiency. However histological and western blot analyses failed to detect any evidence of a subcellular divergence of prion strains, strongly militating against this as the explanation for the apparent increased relative infectivity in the ER/MT marker enriched fractions.
Previous experiments have shown that PrP
res aggregate size affects the efficiency of conversion and prion infection, perhaps through effects on optimising the available templating surface [
30,
31], with oligomers of five or fewer PrP
res molecules and larger fibrillar aggregates of PrP
res far less efficient than non-fibrillar particles of 14-28 molecules [
30]. There is also experimental evidence that a proportion of disease associated prions are protease sensitive [
47‐
49], which may form low molecular weight aggregates [
47,
49]. The results presented herein show that only a minor proportion of prion infectivity within MoRK13-inf fractions is protease sensitive, and is unlikely to account for the disconnect observed between PrP
res levels and infectivity in the ER/MT and lipid raft enriched fractions. Rather, the sonication results are in keeping with a greater proportion of multimeric assemblies, fibrils or aggregated species of prions existing in the lipid raft compared to ER/MT marker enriched fractions, with sonication increasing the number of replication-competent prion oligomeric strand ends which are then more efficient at transmission and inducing prion propagation. Recent publications provide credence to this hypothesis [
68,
69], with direct visualisation of the fragmentation of recombinant PrP after sonication. However, the current study does not exclude any positive effect that sonication may have had on other cellular components contained within the fraction mileu or interactions between the prion protein and other molecules. In fact another recent publication [
70] found that sonication also fragments purified liver RNA, to a size that has previously been shown to stimulate prion conversion in PMCA assays. However the RNA sonication produced optimal (sized) RNA after approximately 8 cycles, whereas our sonication experiment was equivalent to one cycle, giving some support to the plausibility of our former hypothesis. Ongoing studies, including the utilisation of techniques such as the conformation dependent immunoassay (CDI) to measure prions in the fractions [
71], and sophisticated size fractionation techniques, will help clarify the exact biophysical nature of the variably efficient prion species in the lipid raft and ER/MT enriched fractions.
The association of prion infectivity with MT and ER has been previously investigated with conflicting results. One study showed that purified mitochondria and mitoplast fractions from scrapie infected hamster brain contained infectivity titres equivalent to those determined for crude brain homogenate, yet mitoplast fractions were not associated with detectable levels of PrP [
72], in keeping with the findings of the present study. These results, which suggested an association of high levels of scrapie infectivity with the inner mitochondrial membrane or mitochondrial matrix, are broadly consistent with the characteristics of MoRK13-inf ER/MT enriched fractions, which co-localised with the mitochondrial membrane marker Bcl-2 [
73]. An integral and unique (to mitochondria) lipid component of the inner mitochondrial membrane is cardiolipin, a form of dimeric phosphatidylglycerol [
74]. Interestingly, utilizing serial PMCA, researchers have recently been able to produce protease resistant, infectious prions from recombinant PrP mixed with RNA and the synthetic phosphatidylglycerol, POPG (1-palmitoyl-2-oleoylphosphatidylglycerol) [
75]. The authors state that the POPG and RNA additives to their PMCA may be mimicking factors which facilitate the conversion process
in vivo, which is entirely consistent with the results presented here implicating mitochondrial component enriched fractions as containing highly efficient infectious prions.
Somewhat incongruent with these observations, a much earlier study examined the infectivity of scrapie within membrane fractions and found that brain derived purified mitochondrial fractions were associated with very little infectivity [
76]. Nevertheless, similar to our results, Millson and colleagues [
76] did find both brain and spleen derived subcellular fractions containing elevated enzyme activities usually associated with the ER and plasma membrane were associated with high scrapie infectivity. Conversely, Alais and colleagues [
77] found fractions enriched in the ER marker Bip harboured no infectivity, despite containing moderate levels of PrP
res. This result, whilst presenting another example of discrepancy between PrP
res levels and infectivity, clearly contrasts with what was observed in the MoRK13-inf fractions, perhaps reflecting the different methods and prion strain-cell model employed.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
VL performed all experiments. VL, CLH and SJC were involved in the acquisition of data. VL, AFH, VAL and SJC contributed to experimental conception and design. VL, CLH, CLM, AFH, VAL and SJC were involved in analysis and interpretation of data and production of this manuscript. All authors read and approved the final manuscript.